Project
SCREENING AND VALIDATION OF MOLECULES WITH THERAPEUTIC PROPERTIES IN IN VIVO MODELS OF PARKINSON’S DISEASE
| Reference: | SFRH/BD/78077/2011 |
|---|---|
| Funding organization: | Fundação para a Ciência e a Tecnologia |
| Associated institutions: | Universidade de Lisboa |
Similar Items
SCREENING AND VALIDATION OF MOLECULES WITH THERAPEUTIC PROPERTIES IN IN VIVO MODELS OF PARKINSON’S DISEASE
Neuroprotective effects of molecules isolated from Bifurcaria bifurcata and Codium tomentosum in an in vitro and in vivo Parkinson Disease model.
Preclinical Validation of a TNF-Capturing Device as Therapeutics of Inflammatory Arthritic Diseases.
Preclinical Validation of a TNF-Capturing Device as Therapeutics of Inflammatory Arthritic Diseases.
S-Glutathionylation in Parkinson´s Disease.
New Edge in the therapeUtics of PaRkinsON´s diSeaSe from SeaweedS
The transcriptional landscape of Parkinson´s disease
Refining the efficacy of systemic administration of bioactive molecules for Parkinson’s Disease [M-ERA-NET3/0007/2021]
Advanced Maturation in Anisotropic Cardiac Tissues for Disease Modeling and Drug Screening
DEVELOPMENT AND VALIDATION OF VASO-OCCLUSION EARLY PREDICTORS IN A MENDELIAN MODEL OF VASCULAR DISEASE
Chemogenomics screening for novel therapeutic target identification in a C. elegans model of Machado-Joseph disease [SFRH/BD/147826/2019]
Exploring the biophysical link between Gaucher disease and Parkinson?s disease
Pharmacological Modulators of Parkinsons Disease-Associated Proteins
Using Mainstream Devices to Monitor Parkinson´s Disease
DECIPHERING THE ROLE SIRT2 IN PARKINSON DISEASE
Modulating Ire1 to prevent Parkinson' Disease
Underlying role of glycation in the pathogenesis of Parkinsons disease
Cognitive Disorders in Late-Stage Parkinson´s Disease
Cardiovascular risk factors associated with Parkinson´s disease
Modulating Ire1 to prevent Parkinson' Disease
Simplified chip prototyping for improved screening of gene-silencing therapeutics using 3D cell models.
Forefront Research in 3D Disease Cancer Models as in vitro Screening Technologies [668983]
Forefront Research in 3D Disease Cancer Models as in vitro Screening Technologies [668983]
New drugs to target Neurodegenerattion and Neuroinflammation in Parkinson ´s Disease
Dissecting the role of alpha-synuclein phosphorylation in Parkinson’s disease
DECIPHERING THE ROLE OF ALFA-SYNUCLEIN PHOSPHORYLATION IN PARKINSON’S DISEASE
DECIPHERING THE ROLE OF ALFA-SYNUCLEIN PHOSPHORYLATION IN PARKINSON’S DISEASE
Heme/Irin-Driven microglia polarization in Parkinson`s disease
A “Click and CO Release” approach for the targeted delivery of therapeutic CO in vivo
Modeling mitochondrial diseases in Zebrafish: Functional Validation of Genetic Variants of Unknown Significance VUS and strategies to a therapy
Generation of improved cellular and animal models for identification of disease phenotype and new therapeutic targets of Alzheimer’s Disease
Targeting the glycation defenses as a protective strategy for Parkinson’s disease
Targeting the glycation defenses as a protective strategy for Parkinson’s disease
Slow and Rapid Progression Parkinson´s Disease: Molecular Determinants and Biomarkers
Substantia Nigra pars compacta in Parkinson´s Disease: Function and Vulnerability
Nanoparticle-Based Therapeutic Applications and Detection of Carbon Monoxide Releasing Molecules
Toward an understanding of protein glycation in Parkinson's disease: in vitro and in vivo studies of folding, aggregation and degradation pathways of alpha-synuclein, synphilin-1 and parkin under glycation conditions.
Brain-on-a-chip as a preclinical model tool for the screening of theranostic nanoformulations for neurodegenerative diseases [101032481]
Evaluation of the therapeutic properties of oleocanthal, oleacein and analogues
INNOVATIVE WATER-SOLUBLE PHYTOMATERIAL INHIBITORs FOR ALZHEIMERs AND PARKINSONs DISEASES PREVENTION
Related publications
Loading publications...